MOTS-c Peptide: Benefits, Dosage, Side Effects & Stacking Guide

Researchers gave MOTS-c to 22-month-old mice (roughly 70 in human years) for two weeks. Their running capacity doubled. These old mice outperformed untreated middle-aged animals. A single injection 10 minutes before exercise increased running time by 12% and distance by 15%.

That 2021 Nature Communications study changed how scientists think about aging and exercise. MOTS-c isn’t a drug. It’s a signaling molecule your body already makes, mainly in your muscles during exercise. Levels drop as you age. The research question was simple: what happens when you add it back?

I started paying attention to MOTS-c because of the “exercise mimetic” label. It mimics some metabolic effects of working out. Not a replacement for training, but potentially a way to amplify the benefits as natural production declines with age.

Quick note: MOTS-c isn’t FDA-approved. It’s sold as a research compound. This covers what the science shows and what practitioners are doing with it.

MOTS-c Benefits

Based on animal studies and limited human data, here’s what MOTS-c does:

• Improves insulin sensitivity – helps cells use glucose more efficiently, restoring old mice to young animal levels
• Prevents weight gain – mice on high-fat diets didn’t gain weight despite eating the same calories
• Boosts exercise performance – doubled running capacity in old mice within two weeks
• Reduces inflammation – lowers IL-6 and TNF-alpha in multiple animal models
• Protects against muscle wasting – inhibits myostatin, the protein that limits muscle growth
• Supports heart function – restored mitochondrial respiration in diabetic heart tissue
• Slows age-related decline – improved grip strength and walking speed in aged animals
• Supports bone health – reduced bone loss in menopause models
• May extend lifespan – 6.4% median lifespan increase when started late in life

What makes MOTS-c interesting compared to most peptides is the breadth of what it touches. It’s not a single-target compound. Because it works through AMPK activation, the same master switch your body flips during exercise, the downstream effects spread across multiple systems. Your muscles handle glucose better. Your mitochondria produce energy more efficiently. Fat gets burned instead of stored. Inflammation drops. And newer research is showing it even protects the insulin-producing cells in your pancreas from aging out, which matters a lot for long-term metabolic health. Most peptides do one thing well. MOTS-c does several things because it’s tapping into a fundamental metabolic pathway.

If you want to try MOTS-c, quality matters more here than with most peptides because of how fast it degrades. We use Everest Peptides for our MOTS-c. They carry a 40mg vial on sale for $114.99 (regularly $134.99), which works out to a fraction of what most companies charge for the same amount. For comparison, most vendors sell 10mg vials for $65+. With Everest you are getting 4x the product at less than double the price. Third-party tested, US-based, and they handle MOTS-c with proper cold storage and cold-chain shipping. Cards accepted through IDEM Pay. Save another 10% with Pay by Bank. Code BRAINFLOW saves 10%.

Insulin Sensitivity and Diabetes

MOTS-c’s most documented benefit. In the original 2015 study, treated mice showed about 30% better glucose uptake. Old mice had insulin sensitivity restored to young animal levels. The effect was dose-dependent and consistent across multiple trials.

Human observational data lines up with this. People with lower MOTS-c levels tend to have higher BMI, more belly fat, higher fasting insulin, and worse insulin resistance scores. In obese children, plasma MOTS-c correlated negatively with nearly every metabolic marker researchers measured. Adults with poorly controlled type 2 diabetes have significantly lower circulating MOTS-c than those with better blood sugar control.

MOTS-c activates AMPK, which increases glucose transporters on muscle cells. More transporters means more sugar gets pulled from blood into muscles without needing extra insulin. Same thing that happens when you go for a run.

A 2025 study from Harvard and Seoul National University added another layer. They found that MOTS-c levels decline with age specifically in pancreatic islet cells, the ones that produce insulin. When they treated old mouse islets with MOTS-c, it reduced cellular senescence (aging) in those cells and improved glucose tolerance. In diabetic mouse models, MOTS-c treatment slowed diabetes progression by keeping the insulin-producing cells healthier for longer. This shifts the conversation from “MOTS-c helps your muscles use insulin better” to “MOTS-c may also protect the cells that make insulin in the first place.”

Weight and Body Composition

Mice eating a 60% fat diet and treated with MOTS-c for 3-8 weeks showed complete prevention of weight gain. Same calories as untreated mice. They weren’t eating less. They were burning more through increased heat output and improved metabolic efficiency. Separate research has shown MOTS-c increases thermogenesis in adipose tissue, basically turning up your body’s internal furnace, which may also play a role in cold adaptation.

MOTS-c is mechanistically different from GLP-1 drugs like Ozempic. Those work primarily by suppressing appetite and slowing gastric emptying. MOTS-c works on cellular metabolism without affecting hunger. You won’t lose your appetite, but your body gets better at using the calories you consume. Liver fat accumulation was also reduced in treated animals, which matters a lot for anyone dealing with fatty liver or metabolic syndrome.

Exercise Performance

This is the part most people care about. Old mice (22 months) treated for just two weeks ran twice as long and twice as far as untreated old mice. They outperformed untreated middle-aged animals. 17% of treated mice hit the highest sprint speeds versus 0% of untreated controls.

Even a single dose worked. Mice given MOTS-c 10 minutes before exercise showed 12% longer running time and 15% more distance in crossover trials. It works fast once it enters the system.

Important caveat: MOTS-c doesn’t replace training. It mimics the metabolic signaling side of exercise, better glucose handling, improved fat oxidation, your body getting better at switching between fuel sources. But it won’t build muscle mass, improve cardiovascular fitness, or develop sport-specific skills. Think of it as amplifying what exercise does at the cellular level. The stimulus still has to come from you.

Muscle Preservation

This is a newer finding that deserves its own section. A study published in the American Journal of Physiology found that MOTS-c acts as a myostatin inhibitor. Myostatin is the protein your body uses to limit muscle growth. It’s also one of the drivers behind the muscle wasting that comes with obesity and insulin resistance.

In the study, MOTS-c treatment decreased myostatin levels in both blood plasma and muscle tissue of obese mice fed a high-fat diet. The researchers also found that human plasma MOTS-c levels are inversely correlated with myostatin, meaning people with more circulating MOTS-c tend to have lower myostatin. MOTS-c blocked myostatin through an AKT-FOXO1 pathway, preventing the gene expression that triggers muscle breakdown.

This matters for anyone concerned about losing muscle as they age or during weight loss. Most weight loss interventions, GLP-1 drugs included, come with some degree of muscle loss. A compound that simultaneously improves metabolism and protects against muscle wasting fills a real gap.

Heart Health

Heart failure is the leading cause of early death in type 2 diabetes patients, and mitochondrial dysfunction in heart muscle is a big part of why. A 2025 study in Frontiers in Physiology tested whether MOTS-c could help.

They treated diabetic rats with MOTS-c for three weeks and found it restored mitochondrial respiration in heart tissue. The hearts of treated rats produced energy more efficiently, and MOTS-c delayed weight gain in the diabetic animals without affecting how much they ate. Previous research had shown MOTS-c protecting against pressure-induced cardiac hypertrophy and improving heart glucose metabolism in diabetic models. The cardiovascular angle is still early, but the data is building in the same direction.

Aging and Longevity

The longevity data is interesting because it came from late-life intervention, not lifelong treatment. Mice starting MOTS-c at 23.5 months (human equivalent around 70) showed 6.4% longer median lifespan and 7% longer maximum lifespan. The hazard ratio was 0.654, meaning treated mice had about 35% lower risk of death at any given time point.

These old mice didn’t just live longer. They lived better. Grip strength went up. Stride length increased. They walked better on physical tests. Body composition shifted with less fat mass and better preservation of lean tissue. Their metabolic rhythms normalized, showing better ability to switch between burning carbs and fat based on time of day.

Bone health improved too in mice modeling menopause. MOTS-c reduced bone loss by blocking osteoclast activity (the cells that break down bone tissue) through AMPK activation. Worth knowing about if post-menopausal bone health is on your radar.

One note on sex differences: research suggests MOTS-c levels may be more heavily impacted by metabolic conditions in one sex versus the other. The data here is thin, but it’s something researchers are tracking. If you’re a woman considering MOTS-c for metabolic or bone health reasons, the menopause bone data is particularly relevant.

How MOTS-c Works

MOTS-c works differently than most peptides. Instead of binding to a receptor on the cell surface, it enters cells and disrupts a metabolic pathway called the folate-methionine cycle. This causes a compound called AICAR to build up massively, over 20-fold in the original research.

AICAR activates AMPK, often called the body’s “metabolic master switch.” When AMPK turns on, several things happen at once: glucose uptake into muscle cells goes up, fat oxidation increases, insulin sensitivity improves, and mitochondria start working more efficiently. Your muscles do this naturally during exercise, which is why MOTS-c gets the “exercise mimetic” label.

A 2018 study added another piece. Under metabolic stress, MOTS-c moves into the cell nucleus and directly regulates gene expression. It interacts with NRF2, a transcription factor that controls antioxidant defenses. So MOTS-c does double duty. AMPK activation in the cytoplasm and gene regulation in the nucleus.

Then in 2024, researchers identified the exact protein MOTS-c binds to in muscle: an enzyme called CK2. This direct binding explains why the effects are so muscle-specific for glucose uptake.

Your body makes MOTS-c naturally, mostly in skeletal muscle. Production spikes during exercise. A 2021 study found muscle MOTS-c increased nearly 12-fold immediately after high-intensity cycling and stayed at 19-fold four hours later. People who exercise regularly maintain higher baseline levels than sedentary people. The catch: circulating MOTS-c declines as you age, even though muscle tissue actually tries to compensate by producing more locally. The signal gets weaker even as the body tries harder to send it.

Related: Best Peptides for Weight Loss: What Actually Works

MOTS-c Clinical Trials and Human Data

Here’s where you need to be honest with yourself. Native MOTS-c has never been tested in a human clinical trial. All the human trial data comes from CB4211, a modified analog made by a company called CohBar. CB4211 was designed for better stability than native MOTS-c, so the results may not translate directly.

The Phase 1b trial enrolled 20 obese people with fatty liver disease. They took 25 mg daily via subcutaneous injection for 4 weeks. Results:

• ALT down 21% (liver enzyme)
• AST down 28% (liver enzyme)
• Blood glucose down 6%
• About 36% of patients saw significant liver fat reduction
• Well-tolerated with no serious adverse events

The trial paused briefly in November 2018 due to painless bumps at injection sites. This was addressed and the trial resumed, but it’s worth knowing about if you’re considering subcutaneous peptide use.

What does this mean for native MOTS-c? Hard to say. CB4211 is structurally different, built specifically for improved stability and pharmacokinetics. Whether regular MOTS-c produces similar effects in humans at typical research doses remains unknown. The animal data looks promising. The human observational data (lower MOTS-c correlating with worse metabolic health) supports the thesis. But anyone using native MOTS-c is extrapolating from animal studies and anecdotal reports. That’s where things stand right now.

There are currently no active clinical trials testing MOTS-c or any MOTS-c analogs. CohBar’s development program appears to have stalled.

Related: Complete Guide to BPC-157: Benefits, Dosage & What to Expect

MOTS-c Dosage

No human trials exist for native MOTS-c, so dosing protocols come from practitioners and researchers who have worked with the compound. Here’s what different sources recommend:

• Dr. William Seeds: 5mg 3x/week (Mon/Wed/Fri) for 4-6 weeks, then 1x/week maintenance
• Dr. Rob Kominiarek: 10mg 1x/week for 4 weeks
• Ben Greenfield: 10mg weekly before endurance work, max 10 weeks/year
• Common protocol: 5-10mg weekly, split into 2-3 subcutaneous injections

Timing: Morning is generally preferred, ideally 30-60 minutes before fasted exercise. This lines up with natural production patterns during fasting and physical activity. Evening doses may disrupt sleep because of the metabolic activation effects.

Reconstitution: Add bacteriostatic water slowly down the vial side. Never shake because that can damage the peptide. A common setup: 10mg vial + 0.5mL bacteriostatic water = 5mg per 25 units on an insulin syringe. Inject subcutaneously in belly, thigh, or upper arm. Rotate injection sites to avoid tissue irritation.

Here is why dosing matters for sourcing. At the Seeds protocol (5mg 3x/week), a standard 10mg vial from most vendors lasts you about one week. That is $65 gone every seven days. Everest Peptides carries a 40mg vial for $114.99 (on sale from $134.99), which covers roughly four weeks on that same protocol. The math is not even close. Code BRAINFLOW saves 10%, and Pay by Bank knocks off another 10%.

MOTS-c Storage and Stability

MOTS-c is more fragile than most peptides, and if you don’t handle it properly you’re injecting degraded product that won’t do anything. That said, the stability picture is a bit more complicated than most guides make it sound.

In powder form, MOTS-c is stable for months when kept frozen at -20C. No issues there. The fragility kicks in once you reconstitute it.

At room temperature, reconstituted MOTS-c loses about 25% of its activity within 24 hours. Leave it on your counter and you’re throwing money away. But here’s where some older guides get it wrong: a 2023 analysis by Mohtashami et al. found that reconstituted MOTS-c stored at 4C (refrigerator temperature) showed no significant degradation for at least 30 days. The Alzheimer’s Drug Discovery Foundation independently confirmed this finding.

So the practical rules:

• Powder: Freeze at -20C. Good for months.
• Reconstituted: Refrigerate immediately at 4C. Stable for up to 30 days based on current data, though many practitioners still recommend using within 7-14 days to be safe.
• Never leave reconstituted MOTS-c at room temperature. Pull it out, draw your dose, put it back.
• Never freeze reconstituted MOTS-c. Freezing and thawing damages the peptide structure.

If a vendor doesn’t ship cold with ice packs or dry ice, you’re probably getting degraded product before it even arrives. This matters more for MOTS-c than for something like BPC-157 or TB-500 which are far more stable.

MOTS-c Cost and What to Expect

MOTS-c is one of the pricier research peptides. Most vendors sell 10mg vials for $60-90 each. At the common dose of 5mg twice a week, one 10mg vial lasts about a week. A 4-6 week protocol would cost $240-540 in peptide costs alone from those vendors.

This is exactly why I switched to Everest Peptides. They carry a 40mg vial on sale for $114.99 (regularly $134.99). To get the same 40mg from most vendors at $65 per 10mg vial, you would spend $260. With Everest, the same amount costs you less than half that. A single 40mg vial covers roughly 4 weeks at standard dosing.

Stack code BRAINFLOW (10% off) with Pay by Bank (another 10% off) and the math gets even better. Cards are accepted through IDEM Pay if you prefer that route.

As for results, most anecdotal reports describe noticeable effects within 1-2 weeks. Better energy during workouts. Less post-exercise fatigue. Improved fasted morning energy. Some people report visible changes in body composition over 4-6 weeks, though this is hard to separate from training and diet variables. Don’t expect dramatic before-and-after transformations. The effects are more about how you feel during activity and recovery than anything you’d see in the mirror right away.

Stacking MOTS-c

MOTS-c pairs well with other compounds because it works through AMPK activation rather than receptor binding. There is minimal overlap with most other peptides, which makes combining them pretty straightforward.

The most common pairing is MOTS-c with BPC-157. BPC-157 handles tissue repair and gut health while MOTS-c handles metabolism. Completely different mechanisms, zero overlap. A lot of people run these two together during hard training blocks when they want faster recovery and better energy output at the same time.

If you are dealing with a lingering injury but do not want to lose training momentum, adding TB-500 makes sense. TB-500 provides systemic healing through pathways that do not touch what MOTS-c does. Some people go all in and run all three together, the classic Wolverine Stack (BPC-157 + TB-500) with MOTS-c layered on top for the metabolic boost. That covers tissue repair, systemic healing, and metabolic performance in one protocol.

On the longevity side, pairing MOTS-c with Humanin is gaining traction. Both are mitochondrial-derived peptides but they do completely different jobs. Humanin is about neuroprotection and cell survival. MOTS-c is about metabolism. If mitochondrial health is your focus, running both covers more ground than either one alone. NMN or NR (NAD+ precursors) are another popular addition since they support mitochondrial function through NAD+ repletion, a totally separate pathway from AMPK.

One combo to be careful with: MOTS-c and metformin. Both activate AMPK, just in different tissues (metformin in the liver, MOTS-c in skeletal muscle). No formal interaction studies exist, and the concern is too much AMPK activation at once. If you are on metformin, talk to your doctor before adding MOTS-c.

Related: Wolverine Peptide Stack Complete Guide: BPC-157 + TB-500

Side Effects

Safety data for native MOTS-c is limited. The CB4211 trial reported injection site reactions as the most common issue. Animal studies have used doses up to 250 mg/kg without major problems, but that doesn’t guarantee human safety at any dose.

What people report from non-clinical use:

• Injection site reactions (pain, redness, small bumps)
• Increased heart rate or palpitations
• Insomnia, especially with evening dosing
• Headache
• Flushing or feeling warm
• Blood sugar fluctuations
• Mild nausea

Most of these seem dose-dependent and more common when people dose in the evening. Starting low and sticking to morning timing seems to minimize issues based on anecdotal reports.

One thing to know: peripherally administered MOTS-c (subcutaneous injection, how people actually use it) does not appear to cross the blood-brain barrier. A study testing its cognitive effects found zero impact on cognition when given peripherally, even at doses that improved physical capacity. Only centrally administered MOTS-c (directly into the brain, not something people do outside of research) showed cognitive effects. So don’t expect nootropic benefits from your subcutaneous shots.

Legal status: MOTS-c is not FDA approved for any therapeutic use. WADA lists it as prohibited under S4.4 (AMPK activators), banned both in and out of competition. If you compete in tested events, this is off the table.

MOTS-c vs Other Peptides and Drugs

vs GLP-1 drugs (Ozempic, Mounjaro): Completely different mechanisms. GLP-1s suppress appetite and slow gastric emptying. You eat less because you’re not hungry and food sits in your stomach longer. MOTS-c works on cellular metabolism without touching hunger or digestion. GLP-1s produce faster, more dramatic weight loss but often come with nausea, muscle loss, and appetite suppression that some people find miserable. MOTS-c is better suited for metabolic optimization if you’re already eating and training well and want your body to use fuel more efficiently.

vs AOD9604: AOD9604 is an HGH fragment that targets fat cells directly for lipolysis. MOTS-c primarily affects muscle glucose metabolism with secondary effects on body composition. MOTS-c brings broader metabolic benefits including insulin sensitization that AOD9604 doesn’t touch.

vs Humanin: Same family (both mitochondrial-derived), different jobs. Humanin is primarily cytoprotective and neuroprotective. MOTS-c is metabolic. They complement each other rather than compete. You could reasonably use both if mitochondrial health is your focus.

vs Metformin: Both activate AMPK, but they work in different tissues. Metformin primarily acts on the liver. MOTS-c primarily acts on skeletal muscle. Whether their side effect profiles overlap is unknown since no interaction studies exist. Some longevity-focused practitioners use both, but this should be discussed with a doctor.

Related: Best Peptides for Men: What Actually Works in 2026

Who Should Consider MOTS-c

Good candidates:

• People with insulin resistance or prediabetes looking for metabolic support
• Older adults interested in longevity interventions with real animal data behind them
• Endurance athletes competing in non-tested events
• Post-menopausal women focused on metabolic and bone health
• Anyone losing weight who wants to protect against muscle loss during the process
• People interested in mitochondrial function who are already doing the basics right (diet, exercise, sleep)

Probably not the right fit for:

• Anyone wanting rapid weight loss (GLP-1s work better for that)
• Competitive athletes subject to WADA or other drug testing
• People who need established human clinical data before trying something
• Anyone unwilling to deal with cold storage requirements
• People looking for cognitive or nootropic benefits (MOTS-c doesn’t cross the blood-brain barrier when injected subcutaneously)

FDA Status in 2026

On April 15, 2026, HHS Secretary RFK Jr. directed the FDA to remove MOTS-c (along with 11 other peptides) from Category 2 on the 503A bulk drug substances list. This took effect on April 22, 2026. MOTS-c is no longer classified as raising “significant safety concerns.”

The next step is a Pharmacy Compounding Advisory Committee (PCAC) review scheduled for July 23, 2026 at the FDA White Oak Campus. PCAC will evaluate the safety and efficacy evidence and determine whether MOTS-c should be added to Category 1, which would allow licensed compounding pharmacies to legally prepare it with a physician’s prescription.

This is a big shift from where things stood six months ago. If the PCAC review goes favorably, MOTS-c could move from gray-market research peptide to physician-prescribed compounded medication. Quality, accessibility, and standardization would all improve. Our Huberman peptide guide covers the full 2026 regulatory picture.

Where to Buy MOTS-c

Quality matters more for MOTS-c than most peptides because of the stability issue. A vendor with sloppy handling is selling you expensive water. And in an industry where most companies are just middlemen repackaging powder from Chinese labs, knowing who actually tests what they sell is worth paying attention to.

What to look for:

• Third-party Certificate of Analysis with purity data (98%+ minimum)
• Batch-specific testing, not generic COAs reused across batches
• Cold-chain shipping with ice packs or dry ice
• Proper frozen storage before shipping
• Transparent pricing without hiding behind “contact us for a quote”

Red flags: No COAs available, prices way below market rate, no cold shipping option, vague answers about storage and handling, or a company that popped up six months ago with no track record.

Our readers and I use Everest Peptides for MOTS-c and we have been recommending them for a while now. Here is why:

• 40mg vial for $114.99 (on sale from $134.99). Most vendors charge $65+ for 10mg. That is 4x the product at less than double the price. The per-mg cost is not even close.
• Third-party tested US company. COAs available on the product page. You can verify what you are getting before you inject it.
• Proper MOTS-c handling: Cold storage and cold-chain shipping. Given how fast this peptide degrades at room temperature, this alone sets them apart from vendors who toss vials in a padded envelope.
• Flexible payment: Cards accepted through IDEM Pay. Pay by Bank saves an additional 10% on top of any coupon code.

Code BRAINFLOW saves 10% on your order. Stack that with Pay by Bank for maximum savings.

Frequently Asked Questions

Does MOTS-c work for weight loss?

In mice, MOTS-c completely prevented weight gain on a high-fat diet without reducing food intake. It works by increasing metabolic rate and thermogenesis rather than suppressing appetite. If you’re looking for dramatic, fast weight loss like what GLP-1 drugs deliver, MOTS-c isn’t the right tool. It’s better suited for dialing in your metabolism and preventing fat accumulation while you’re already training and eating well.

How long does MOTS-c take to work?

A single dose showed measurable effects on exercise performance in mice within 10 minutes. For humans, most anecdotal reports describe noticeable changes in energy and exercise performance within 1-2 weeks. Body composition changes, if they happen, typically take 4-6 weeks to become apparent. The old mice in the Nature Communications study showed doubled running capacity after just two weeks of treatment.

Can you take MOTS-c with metformin?

Both activate AMPK, but they act on different primary tissues (metformin on the liver, MOTS-c on skeletal muscle). No formal interaction studies exist. Some longevity practitioners use both, but this should absolutely be discussed with a doctor. The concern is excessive AMPK activation, though nobody knows what that looks like in practice.

Is MOTS-c legal?

MOTS-c is sold as a research compound in the US. It is not FDA-approved for therapeutic use. As of April 22, 2026, MOTS-c has been removed from the FDA’s Category 2 list and is scheduled for PCAC review in July 2026. WADA banned it under S4.4 (AMPK activators) starting in 2024, so competitive athletes in tested sports cannot use it. For non-competitive personal use, it exists in a legal gray area similar to other research peptides.

Does MOTS-c help with brain function or focus?

No, not when injected subcutaneously (the way people actually use it). Research shows peripherally administered MOTS-c does not cross the blood-brain barrier. At doses that improved physical capacity in mice, there was zero effect on cognition. Only centrally administered MOTS-c (directly into the brain in a lab setting) showed cognitive benefits. Don’t expect nootropic effects from subcutaneous injections.

How much does MOTS-c cost?

Most vendors charge $60-90 for a 10mg vial. Everest Peptides carries a 40mg vial for $114.99 (on sale from $134.99), which works out to roughly $2.87/mg versus $6.50/mg from typical vendors. At standard dosing, one Everest vial covers about 4 weeks. Code BRAINFLOW saves 10%, and Pay by Bank saves another 10% on top.

Does MOTS-c protect against muscle loss?

Recent research says yes. A study in the American Journal of Physiology found that MOTS-c acts as a myostatin inhibitor, reducing the protein responsible for limiting muscle growth and driving muscle wasting. In obese mice, MOTS-c treatment decreased myostatin levels in both blood and muscle tissue. Human data showed an inverse correlation between circulating MOTS-c and myostatin levels. This is relevant for anyone losing weight, aging, or dealing with metabolic conditions that accelerate muscle breakdown.

Bottom Line

MOTS-c is a mitochondrial peptide that mimics some of the metabolic effects of exercise. The animal data is solid: it prevents diet-induced obesity, improves insulin sensitivity by about 30%, doubles exercise capacity in old mice, protects against muscle wasting, supports heart function in diabetic models, and extends lifespan by 6.4% when started late in life. Newer studies are adding to the picture, showing it can protect insulin-producing pancreatic cells from aging and inhibit myostatin to preserve muscle mass.

The gaps are real though. No human trials with native MOTS-c exist. Dosing is based on practitioner experience and animal data extrapolation. The peptide degrades at room temperature, which creates practical handling challenges. And it’s not cheap from most vendors.

For people who are already doing the fundamentals right and want to push further on metabolic health and longevity, MOTS-c offers something different from other options. It won’t replace exercise or diet. But it might make them work harder for you, especially as natural MOTS-c production drops with age. Whether that trade-off makes sense for you depends on your goals, your budget, and your comfort level with a compound that has strong animal data but limited human evidence.

MOTS-c 40mg → Everest Peptides · Code BRAINFLOW Saves 10%

References

• Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015. PubMed
• Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline. Nature Communications. 2021. PubMed
• Kim KH, et al. MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. 2018. PubMed
• Ming W, et al. MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation. BBRC. 2016. PubMed
• Kang GM, et al. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience. 2024. PubMed
• Kumagai H, et al. MOTS-c reduces myostatin and muscle atrophy signaling. American Journal of Physiology-Endocrinology and Metabolism. 2025. AJP
• Kong BS, et al. Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Experimental & Molecular Medicine. 2025. PubMed
• Pham T, et al. Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic heart. Frontiers in Physiology. 2025. Frontiers
• Lu H, et al. Mitochondrial-Derived Peptide MOTS-c Increases Adipose Thermogenic Activation to Promote Cold Adaptation. Int J Mol Sci. 2019. PubMed

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice. MOTS-c is not FDA-approved and is sold only as a research compound. Consult a qualified healthcare provider before use. This article contains affiliate links to Everest Peptides. We may earn a commission if you purchase through these links at no additional cost to you.